닫기
216.73.216.142
216.73.216.142
close menu
SCIE SCOPUS
한국 독사독으로부터의 혈전 용해제 개발에 관한 연구 2. 살모사 ( A. bromhoffi brevicaudus ) 사독 Protease 의 특성과 혈전 용해능에 관한 연구
Studies on the Development of a Thrombolytic Agent from Korean Snake Venom 2. Characterization and Thrombolytic Activity of a Protease from the Venom of A. bromhoffi brevicaudus
김병재(Byoung Jae KIm),이문한(Mun Han Lee),임종섭(Jong Seop Rim),이항(Hang Lee),이혜숙(Hye Suk Lee),김종호(Jong Ho Kim),채창수(Chang Su Chai)
UCI I410-ECN-0102-2009-510-008087140
* 발행 기관의 요청으로 무료로 이용 가능한 자료입니다.

The biochemical properties of the fibrinolytic protease of 50,800 Da isolated from the venom of Agkistrodon blomhoffi brevicaudus were characterized. The enzyme hydrolyzed the carboxyl side of arginine in the synthetic chromogenic peptides, N-Benzoyl-Phe-Val-Arg-pNA and N p-Tosyl-Gly-Pro-Arg-pNA, and the enzyme activity was inhibited by phenylmethylsulfonylfluoride indicating that the enzyme belongs to the serine protease family. The protease showed maximum activity at pH 7.5 and inhibited by ZnCl₂, CuSO₄, but not by soybean trypsin inhibitor, pepstatin A, 2-mercaptoethanol and EDTA. The Km value determined with Np-Tosyl-Gly-Pro-Arg-pNA was 0.2 mM. The thrombolytic activity of the purified enzyme was evaluated by platelet aggregation test in rabbits. While the platelet count ratio in blood of the rabbits injected with thrombin alone declined from 1.0 to 0.6 within 7 min and maintained around 0.6 for 24 hours thereafter, the ratio rapidly recovered from around 0.6 to 0.8 in 1 hr, to 1.0 in 24 hrs when the rabbits were sequentially treated with thrombin and the purified enzyme. The result showed that the serine protease from A. blomhoffi brevicoudus of 50,800 Da had a thrombolytic activity in vivo and the enzyme might be developed as a therapuetic agent for the treatment of thrombic disease.

[자료제공 : 네이버학술정보]
×